2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (Compound)

Synonyms:PF-04217903, 956905-27-4, PF04217903, 1159490-85-3, 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol, PF 04217903, PF-4217903, CYJ9ATV1IJ, Met tyrosine kinase inhibitor PF-04217903, CHEMBL2001019, 2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol, 956905-27-4 (free base), 2-(4-(1-(Quinolin-6-ylmethyl)-1H-(1,2,3)triazolo(4,5-b)pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol, PF-04217903 (phenolsulfonate), 1H-Pyrazole-1-ethanol, 4-(1-(6-quinolinylmethyl)-1H-1,2,3-triazolo(4,5-b)pyrazin-6-yl), 2-{4-[1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL]-1H-PYRAZOL-1-YL}ETHANOL, UNII-CYJ9ATV1IJ, 3zxz, 2-[4-[1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazol-1-yl]ethanol, Kinome_3829, SCHEMBL93550, MLS006010959, CHEBI:91425, EX-A478, DTXSID401026097, HMS3244G11, HMS3244G12, HMS3244H11, HMS3295M07, HMS3654I19, AMY23856, BCP01847, BDBM50396934, MFCD12407410, NSC763931, NSC800845, s1094, AKOS026750596, CCG-264818, CS-0147, DB12848, NSC-763931, NSC-800845, SB19372, 2-[4-(3-Quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-ethanol, NCGC00263161-01, NCGC00263161-03, NCGC00263161-11, NCGC00263161-15, 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol, 2-(4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol, 2-{4-[1-(6-Quinolinylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-y l]-1H-pyrazol-1-yl}ethanol, AC-35476, AS-16216, HY-12017, SMR004702763, FT-0700423, SW218126-2, EC-000.2351, A858951, J-505841, BRD-K73319509-001-01-5, PF-04217903,PF-4217903, Q27163274, 2-(4-(1-(isoquinolin-7-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol, KRW

Pubchem:PUBCHEM:17754438

Id:a9bd40b4-5216-519a-aa2a-450a06a05e35

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol.

Results found

Linked to

	Label	Description
	BRD-K73319509-001-08-0 Substance (Entity type)	A Substance
	pf-04217903 (14de03c0-d323-4c48-a4e3-162851161720) Collection (Entity type)	Metadatata for pf-04217903
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates SFRP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates PAX5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates MGP Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates IGFBP5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol negatively regulates VEGFA Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates PROM1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates ADI1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Clinofibrate in similarity relationship with 2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K73319509-001-08-0

Substance (Entity type)

A Substance

pf-04217903 (14de03c0-d323-4c48-a4e3-162851161720)

Collection (Entity type)

Metadatata for pf-04217903

2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol positively regulates SFRP1

Knowledge Graph Assertion (Entity type)